Publications by authors named "Asa Choen"

Claim this Profile
T
The safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T mutation, supports a Phase 1/2 clinical study.
Lital Friedman, Ofra-Barchad Avitzur, Efrat Ozeri Galai, Nicolay Ferrari, Asa Choen

Expert Opin Drug Metab Toxicolยท November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis